Bisphosphonates are a drugs that treat bone problems, such as thin or fragile bones. Bisphosphonates are enzyme-resistant analogues of pyrophosphate, which normally inhibits mineralization in the bone. Their effect is dose dependent and they reduce the turnover of bone by inhibiting recruitment and promoting apoptosis of osteoclasts. Bisphosphonates are used to treat postmenopausal and glucocorticoid induced osteoporosis, Paget's disease of bone and malignant hypercalcemia.
This report contains market size and forecasts of Bisphosphonates in global, including the following market information:
Global Bisphosphonates Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Bisphosphonates Market Sales, 2017-2022, 2023-2028, (MT)
Global top five Bisphosphonates companies in 2021 (%)
The global Bisphosphonates market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Alendronate Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Bisphosphonates include Merck, Teva, Mylan, Apotex Corp, Pfizer, Sanofi, Roche, Novartis and Eli Lilly, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Bisphosphonates manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Bisphosphonates Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Bisphosphonates Market Segment Percentages, by Type, 2021 (%)
Alendronate
Ibandronate
Risedronate
Zoledronic Acid
Global Bisphosphonates Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Bisphosphonates Market Segment Percentages, by Application, 2021 (%)
Metastatic Bone Cancers
Systemic Metabolic Bone Diseases
Global Bisphosphonates Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Bisphosphonates Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Bisphosphonates revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Bisphosphonates revenues share in global market, 2021 (%)
Key companies Bisphosphonates sales in global market, 2017-2022 (Estimated), (MT)
Key companies Bisphosphonates sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
Teva
Mylan
Apotex Corp
Pfizer
Sanofi
Roche
Novartis
Eli Lilly
Amgen
Tecoland
Emcure Pharma
Taj Pharmaceuticals
Natco Pharma
Scinopharm Taiwan
Lianyungang Runzhong Pharmaceutical
Hangzhou Longshine Bio-Tech